News

Success for some is the measure of wealth they have accumulated, while for some it is the respect they have earned. The word holds different meaning for different people. For Emmanuel Vincent, the Co-founder and CEO of Aenitis Technologies, it is the measure of how many lives he has saved or improved. Although, together we can move mountains but the strong determination and perseverance of one person can also make a difference in this world and that is what this 41-year young healthcare leader is set to do. Emmanuel is driven by activities involving social impact and is value creation oriented.

Paris, July 2, 2015 – Aenitis Technologies : Winner of 17th Contest in Category I-lab Creation Development of the Ministry of Research and Higher Education. Created in July 2014, Aenitis Technologies is a young French start-up from born from the work of Mauricio Hoyos and Jean-Luc AIDER, researchers at the CNRS Laboratory of Physics and Mechanics of Heterogeneous Media (PMMH) at ESPCI. The company focuses its activities in the medical devices sector where the impact of technology breaks it develops strongly wearer.. This significant support from the Ministry of Research and Higher Education will contribute

Paris, October 19, 2016 – Aenitis Technologies, a company that develops new medical devices based on acoustic manipulation mechanisms for biological particles, is announcing that FIST SA, the CNRS’ technology exploitation subsidiary, has acquired an interest in its capital ‍ France Innovation Scientifique et Transfert SA (FIST SA) has established a stake in the capital of the company founded in July 2014 by Mauricio Hoyos and Jean-Luc Aider, two CNRS research scientists working in the Laboratory of Physics and Mechanics of Heterogeneous Environments (CNRS, ESPCI, UPMC, Université Paris Diderot), and Emmanuel Vincent. Aenitis Technologies is

This funding will help to accelerate the roll-out of acoustic blood cell sorting technology to industrial scale Aenitis Technologies, which develops new medical equipment based on acoustic manipulation of biological particles, today announced that it has received €4 million in funding, following its application to the highly-selective SME Instrument Phase 2 European programme, in the “Healthcare Biotechnology” category. SME Instrument Phase 2 is part of Horizon 2020, a programme managed by the European Commission and dedicated to innovation and research. It is part of the Industrial Leadership pillar of H2020 and seeks to support fast-growing,

We are proud to announce that Aenitis Technologies has been awarded the 1st prize in the European EIT Health Catapult in the Medtech category. The jury was keen to reward the potential of our company and the quality of our Pitch!

Paris, december 19th 2018 – Aenitis technologies, which develops new medical devices  for cell manipulation and sorting based on the use of acoustic energy, was named laureate, in the health category, of the first wave of the innovation competition organized by bpifrance under the aegis of cgi, ademe and franceagrimer. This contest, which was first launched in december of 2017, aims to support innovative projects created by sme and start-up companies in order to foster the emergence of world-class french champions on major issues, especially in the field of health, new challenges for producing biological

The second semester of 2018 was full of events for Aenitis Technologies. Let’s take these final few moments of the year to reminisce on the last six months: August: Acoustofluidic: Aenitis Technologies was a sponsor for the event that took place from August 29th to 31st in Lille. This annual gathering is dedicated to science, engineering and the use of acousto-fluidics from the micro to nanoscale. Our CEO, Emmanuel Vincent, gave a conference about the valorization of academic developments in acousto-fluidics through industrial swarming and startup companies. September : Access2Europe: The team of Aenitis Technologies

Aenitis Technologies was this week at the France Tech Transfer Invest (FTTI), thanks to the support of CNRS Innovation! Organized by Bpifrance, the SATT Network, CNRS, Inserm Transfert, INRIA and CEA – in partnership with the Tech Tour company – this two-days event brought together forty start-ups stemming from French research. We are very proud to have been able to participate and present our technology to nearly 70 French and international investors specialized in innovation.We are also pleased to have won the FTTI 2019 competition and to be one of three Medtech start-ups for the

BIO Europe Hamburg – Tuesday November 12 th from 9am to 10:30 am -Emmanuel Vincent, CEO Aenitis Technologies, will present the experience of Aenitis with the SME instrument

Aenitis Technologies has been selected for the €10,000 grant in the EIT Health Summit programme